Your browser doesn't support javascript.
loading
Therapeutic potential and limitations of curcumin as antimetastatic agent.
Dytrych, Petr; Kejík, Zdenek; Hajduch, Jan; Kaplánek, Robert; Veselá, Katerina; Kucnirová, Katerina; Skalicková, Markéta; Venhauerová, Anna; Hoskovec, David; Martásek, Pavel; Jakubek, Milan.
Afiliación
  • Dytrych P; 1st Department of Surgery-Department of Abdominal, Thoracic Surgery and Traumatology, First Faculty of Medicine, Charles University and General University Hospital, U Nemocnice 2, 121 08 Prague, Czech Republic.
  • Kejík Z; BIOCEV, First Faculty of Medicine, Charles University, Prumyslová 595, 252 50 Vestec, Czech Republic; Department of Paediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital in Prague, Ke Karlovu 455/2, 128 08 Prague, Czech Republic.
  • Hajduch J; BIOCEV, First Faculty of Medicine, Charles University, Prumyslová 595, 252 50 Vestec, Czech Republic.
  • Kaplánek R; BIOCEV, First Faculty of Medicine, Charles University, Prumyslová 595, 252 50 Vestec, Czech Republic.
  • Veselá K; BIOCEV, First Faculty of Medicine, Charles University, Prumyslová 595, 252 50 Vestec, Czech Republic; Department of Paediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital in Prague, Ke Karlovu 455/2, 128 08 Prague, Czech Republic.
  • Kucnirová K; BIOCEV, First Faculty of Medicine, Charles University, Prumyslová 595, 252 50 Vestec, Czech Republic; Department of Paediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital in Prague, Ke Karlovu 455/2, 128 08 Prague, Czech Republic.
  • Skalicková M; BIOCEV, First Faculty of Medicine, Charles University, Prumyslová 595, 252 50 Vestec, Czech Republic; Department of Paediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital in Prague, Ke Karlovu 455/2, 128 08 Prague, Czech Republic.
  • Venhauerová A; BIOCEV, First Faculty of Medicine, Charles University, Prumyslová 595, 252 50 Vestec, Czech Republic; Department of Paediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital in Prague, Ke Karlovu 455/2, 128 08 Prague, Czech Republic.
  • Hoskovec D; 1st Department of Surgery-Department of Abdominal, Thoracic Surgery and Traumatology, First Faculty of Medicine, Charles University and General University Hospital, U Nemocnice 2, 121 08 Prague, Czech Republic.
  • Martásek P; Department of Paediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital in Prague, Ke Karlovu 455/2, 128 08 Prague, Czech Republic. Electronic address: pavel.martasek@lf1.cuni.cz.
  • Jakubek M; BIOCEV, First Faculty of Medicine, Charles University, Prumyslová 595, 252 50 Vestec, Czech Republic; Department of Paediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital in Prague, Ke Karlovu 455/2, 128 08 Prague, Czech Republic.
Biomed Pharmacother ; 163: 114758, 2023 Jul.
Article en En | MEDLINE | ID: mdl-37141738
ABSTRACT
Treatment of metastatic cancer is one of the biggest challenges in anticancer therapy. Curcumin is interesting nature polyphenolic compound with unique biological and medicinal effects, including repression of metastases. High impact studies imply that curcumin can modulate the immune system, independently target various metastatic signalling pathways, and repress migration and invasiveness of cancer cells. This review discusses the potential of curcumin as an antimetastatic agent and describes potential mechanisms of its antimetastatic activity. In addition, possible strategies (curcumin formulation, optimization of the method of administration and modification of its structure motif) to overcome its limitation such as low solubility and bioactivity are also presented. These strategies are discussed in the context of clinical trials and relevant biological studies.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Curcumina / Neoplasias / Antineoplásicos Límite: Humans Idioma: En Revista: Biomed Pharmacother Año: 2023 Tipo del documento: Article País de afiliación: República Checa

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Curcumina / Neoplasias / Antineoplásicos Límite: Humans Idioma: En Revista: Biomed Pharmacother Año: 2023 Tipo del documento: Article País de afiliación: República Checa